Cheng G

No ORCID on file · 7 papers in corpus · active 2018-2026

Study types

  • article 1
  • other 1
  • preprint 1
  • review 1

Condition tags

  • endometriosis 3
review 2026
Frontiers in immunology ·doi:10.3389/fimmu.2026.1753651

Gynecological diseases represent a persistent global health burden. According to a WHO report, the global incidence of gynecological diseases exceeds 65%. Furthermore, over 90% of women suffer from gynecological issues to varying degrees. T…

other 2025
Reproductive medicine and biology ·doi:10.1002/rmb2.12644

PURPOSE: Endometriosis is a prevalent gynecological disorder, yet data on the role of trace metal elements in its risk remain limited. We aimed to investigate the relationship between serum copper (Cu), zinc (Zn), iron (Fe), magnesium (Mg) …

preprint 2024
·doi:10.21203/rs.3.rs-4511841/v1

Abstract The significance of trace metal elements in the development of endometriosis has garnered increasing interest. We aimed to investigate the relationship between serum copper (Cu), zinc (Zn), iron (Fe), magnesium (Mg) levels, and th…

2024
Theranostics ·doi:10.7150/thno.99257

The therapeutic efficacy of drugs is determined, to a certain extent, by the efficiency of drug delivery. The low efficiency of drug delivery systems (DDSs) is frequently associated with serious toxic side effects and can even prove fatal i…

article 2020
Chinese medicine ·doi:10.1186/s13020-020-00392-0

BACKGROUND: Yuzhi Zhixue Granule (YZG) is a traditional Chinese patent medicine for treating excessive menstrual flow caused by ovulatory dysfunctional uterine bleeding (ODUB) accompanied by heat syndrome. However, the underlying molecular …

2019
Frontiers in immunology ·doi:10.3389/fimmu.2019.00980

Acute pancreatitis (AP) is a common and devastating inflammatory disorder of the pancreas. However, there are still no effective treatments available for the disease. Therefore, it is important to discover new therapeutic targets and strate…

2018
Cell death & disease ·doi:10.1038/s41419-017-0197-y

Hormone therapy drugs, such as bicalutamide and enzalutamide, directed against prostate cancer focus on androgen receptor (AR) signaling and are initially effective, but the disease progresses to lethality as resistance to these drugs devel…